416 related articles for article (PubMed ID: 23317057)
1. Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.
Bai Q; Desprat R; Klein B; Lemaître JM; De Vos J
Curr Gene Ther; 2013 Apr; 13(2):93-8. PubMed ID: 23317057
[TBL] [Abstract][Full Text] [Related]
2. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?
Boué S; Paramonov I; Barrero MJ; Izpisúa Belmonte JC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862250
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
Quattrocelli M; Thorrez L; Sampaolesi M
Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
[TBL] [Abstract][Full Text] [Related]
4. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation dynamics in human induced pluripotent stem cells over time.
Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A
PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780
[TBL] [Abstract][Full Text] [Related]
6. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
7. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
8. Human induced pluripotent stem cells--from mechanisms to clinical applications.
Drews K; Jozefczuk J; Prigione A; Adjaye J
J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
[TBL] [Abstract][Full Text] [Related]
9. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
[TBL] [Abstract][Full Text] [Related]
11. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
12. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
Yoshihara M; Oguchi A; Murakawa Y
Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
15. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective.
Liang G; Zhang Y
Cell Res; 2013 Jan; 23(1):49-69. PubMed ID: 23247625
[TBL] [Abstract][Full Text] [Related]
17. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer: A Horse in the Race?
Wolf DP; Morey R; Kang E; Ma H; Hayama T; Laurent LC; Mitalipov S
Stem Cells; 2017 Jan; 35(1):26-34. PubMed ID: 27612640
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
[TBL] [Abstract][Full Text] [Related]
20. The Number of Point Mutations in Induced Pluripotent Stem Cells and Nuclear Transfer Embryonic Stem Cells Depends on the Method and Somatic Cell Type Used for Their Generation.
Araki R; Mizutani E; Hoki Y; Sunayama M; Wakayama S; Nagatomo H; Kasama Y; Nakamura M; Wakayama T; Abe M
Stem Cells; 2017 May; 35(5):1189-1196. PubMed ID: 28233378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
